Publication Cover
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 45, 2016 - Issue 6
310
Views
8
CrossRef citations to date
0
Altmetric
Original Articles

Neutrophil CD64 as a Marker of Bacterial Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease

&

References

  • Agarwal R, Schwartz DN. (2011). Procalcitonin to guide duration of antimicrobial therapy in intensive care units: A systematic review. Clin Infect Dis 53(3), 379–87.
  • Anthonisen NR, Manfreda J, Warren CPW, et al. (1987). Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med, 106(2), 196–204.
  • Blasi F, Mantero M, Aliberti S. (2012). Antibiotics as immunomodulant agents in COPD. Curr Opin Pharmacol, 12(3), 293–9.
  • Butorac-Petanjek B, Parnham MJ, Popović-Grle S. (2010). Antibiotic therapy for exacerbations of chronic obstructive pulmonary disease (COPD). J Chemother, 22(5), 291–7.
  • Celli BR, Barnes PJ. (2007). Exacerbations of chronic obstructive pulmonary disease. Eur Respir J, 29(6), 1224–38.
  • Danikas DD, Karakantza M, Theodorou G L, et al. (2008). Prognostic value of phagocytic activity of neutrophils and monocytes in sepsis. Correlation to CD64 and CD14 antigen expression. Clin Exp Immunol, 154(1), 87–97.
  • Daryapeyma A, Pedersen G, Laxdal E, et al. (2009). Neutrophil CD64 as a marker for postoperative infection: A pilot study. Eur J Vasc Endovasc Surg, 38(1), 100–3.
  • Dev D, Wallace E, Sankaran R, et al. (1998). Value of C-reactive protein measurements in exacerbations of chronic obstructive pulmonary disease. Respir Med, 92(4), 664–7.
  • Dimoula A, Pradier O, Kassengera Z, et al. (2014). Serial determinations of neutrophil CD64 expression for the diagnosis and monitoring of sepsis in critically ill patients. Clin Infect Dis, 58(6), 820–9.
  • Du FB, Yang WC, Lei ZB. (2013). Value of neutrophil CD64 index in guiding the therapy for acute exacerbation of chronic obstructive pulmonary disease. Anhui Med Pharm J, 17(4), 596–8.
  • Elawady S, Botros SK, Sorour AE, et al. (2014). Neutrophil CD64 as a diagnostic marker of sepsis in neonates. J Invest Med, 62(3), 644–9.
  • Gilbert DN. (2011). Procalcitonin as a biomarker in respiratory tract infection. Clin Infect Dis, 52(Suppl 4), S346–50.
  • Goulding NJ, Knight SM, Godolphin JL, Guyre PM. (1992). Increase in neutrophil Fc gamma receptor I expression following interferon gamma treatment in rheumatoid arthritis. Ann Rheum Dis, 51(4), 465–8.
  • Guyre PM, Campbell AS, Kniffin WD, Fanger MW. (1990). Monocytes and polymorphonuclear neutrophils of patients with streptococcal pharyngitis express increased numbers of type I IgG Fc receptors. J Clin Invest, 86(6), 1892–6.
  • Herra CM, Keane CT, Whelan A. (1996). Increased expression of Fcγ receptors on neutrophils and monocytes may reflect ongoing bacterial infection. J Med Microbiol 44(2), 135–40.
  • Hoffmann JJ. (2009). Neutrophil CD64: A diagnostic marker for infection and sepsis. Clin Chem Lab Med 47(8), 903–16.
  • Hogg JC. (2004). Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet, 364(9435), 709–21.
  • Kerst JM, Van de Winkel JG, Evans AH, et al. (1993). Granulocyte colony-stimulating factor induces hFc gamma RI (CD64 antigen)-positive neutrophils via an effect on myeloid precursor cells. Blood, 81(6), 1457–64.
  • Kolackova M, Kudlova M, Kunes P, et al. (2008). Early expression of FcγRI (CD64) on monocytes of cardiac surgical patients and higher density of monocyte anti-inflammatory scavenger CD163 receptor in “on-pump” patients. Mediators Inflamm, Article ID 235461: 1–6.
  • Korppi M, Kröger L, Laitinen M. (1993). White blood cell and differential counts in acute respiratory viral and bacterial infections in children. Scand J Infect Dis, 25(4), 435–40.
  • MacNee W. (2005). Pathogenesis of chronic obstructive pulmonary disease. Proc Am Thorac Soc, 2(4), 258–66.
  • Mao W, Jiang Y, Ouyang L, et al. (2014). Early diagnostic values of CD64 and CD11b indices of peripheral white blood cells for acute exacerbation of chronic obstructive pulmonary disease in older adults. Chin J Cell Mol Immunol, 30(11), 1201–4.
  • Mathers CD, Loncar D. (2006). Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med, 3(11), e442.
  • Ng PC, Li K, Wong RPO, et al. (2002). Neutrophil CD64 expression: a sensitive diagnostic marker for late-onset nosocomial infection in very low birthweight infants. Pediatr Res, 51(3), 296–303.
  • Nimmerjahn F, Ravetch JV. (2006). Fcγ receptors: Old friends and new family members. Immunity, 24(1), 19–28.
  • Pagella F, De Amici M, Matti E, et al. (2013). CD64 expression on monocytes in children with adenoid hypertrophy. Asian Pac J Allergy Immunol, 31(2), 132–7.
  • Peng C, Tian C, Zhang Y, et al. (2013). C-reactive protein levels predict bacterial exacerbation in patients with chronic obstructive pulmonary disease. Am J Med Sci, 345(3), 190–4.
  • Rabe KF, Hurd S, Anzueto A, et al. (2007). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care, 176(6), 532–55.
  • Radaev S, Sun P. (2002). Recognition of immunoglobulins by Fcγ receptors. Mol Immunol, 38(14), 1073–83.
  • Rothberg MB, Pekow PS, Lahti M, et al. (2010). Antibiotic therapy and treatment failure in patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. JAMA, 303(20), 2035–42.
  • Sethi S. (2005). Pathogenesis and treatment of acute exacerbations of chronic obstructive pulmonary disease. Semin Respir Crit Care Med, 26(2), 192–203.
  • Sexton P, Black P, Wu L, et al. (2014). Chronic obstructive pulmonary disease in non-smokers: A case-comparison study. COPD, 1(1), 2–9.
  • Streimish I, Bizzarro M, Northrup V, et al. (2014). Neutrophil CD64 with hematologic criteria for diagnosis of neonatal sepsis. Am J Perinatol 31(1), 21–30.
  • Tanaka S, Nishino J, Matsui T, et al. (2009). Neutrophil CD64 expression in the diagnosis of local musculoskeletal infection and the impact of antibiotics. J Bone Joint Surg Br, 91(9), 1237–42.
  • Tanrıverdi H, Örnek T, Erboy F, et al. (2015). Comparison of diagnostic values of procalcitonin, C-reactive protein and blood neutrophil/lymphocyte ratio levels in predicting bacterial infection in hospitalized patients with acute exacerbations of COPD. Wien Klin Wochenschr, 127(19–20), 1–8.
  • Vestbo J, Hurd SS, Agusti AG, et al. (2013). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care, 187(4), 347–65.
  • Yu QQ, Wang HP, Zhai ZM, Zhao YM. (2011). Clinical significance of determination of neutrophil CD64 mean fluorescence intensity index using flow cytometry in diagnosis of infection diseases. Clin Focus 26(5), 383–7.
  • Zhang LX, Ye J, Chen YB, et al. (2013). The effect of CD33 expression on inflammatory response in chronic obstructive pulmonary disease. Immunol Invest, 42(8), 701–10.
  • Zhong N, Wang C, Yao W, et al. (2007). Prevalence of chronic obstructive pulmonary disease in China: A large, population-based survey. Am J Respir Crit Care, 176(8), 753–60.
  • Zhu Y, Cao X, Zhang K, et al. (2014). Delta mean neutrophil volume (ΔMNV) is comparable to procalcitonin for predicting postsurgical bacterial infection. J Clin Lab Anal 28(4), 301–5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.